Video index

1. Call to order

2. Consideration of October 25, 2024, draft meeting minutes

3. HHS ethics policy overview and refresher for members

4. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

5. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL

6. Therapeutic and clinical drug reviews and updates, discussion, and recommendations: Gainwell Technologies and DURB members

7. Executive work session

8. Announcements of drugs recommended for the Medicaid PDL: OptumRx

9. Retrospective drug utilization review (DUR): Acentra Health

10. Prospective prior authorization proposals: Acentra Health

11. Retrospective drug use criteria for outpatient use in Vendor Drug Program

12. Review of action items for next meeting: April 25, 2025, 9:00 a.m.

Jan 31, 2025 Drug Utilization Review Board (DURB) Agenda

Full agenda
Share this video

1. Call to order

2. Consideration of October 25, 2024, draft meeting minutes

3. HHS ethics policy overview and refresher for members

4. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

5. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL

6. Therapeutic and clinical drug reviews and updates, discussion, and recommendations: Gainwell Technologies and DURB members

7. Executive work session

8. Announcements of drugs recommended for the Medicaid PDL: OptumRx

9. Retrospective drug utilization review (DUR): Acentra Health

10. Prospective prior authorization proposals: Acentra Health

11. Retrospective drug use criteria for outpatient use in Vendor Drug Program

12. Review of action items for next meeting: April 25, 2025, 9:00 a.m.

© 2003-2025 Swagit Productions, LLC